U Square Lifescience Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: U Square Lifescience Private Limited Pharmaceutical Export Portfolio Dataset — 2 Products, $433.2K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

U Square Lifescience Private Limited — Pharmaceutical Exporter Profile (2026) | 2 Products, $433.2K Trade | TransData Nexus

U Square Lifescience Private Limited

Indian Pharmaceutical Exporter · Cardiovascular Specialist · $433.2K Total Trade · DGFT Verified

U Square Lifescience Private Limited is an Indian pharmaceutical exporter with a total trade value of $433.2K across 2 products in 2 therapeutic categories. Based on 11 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Heparin ($400.0K), Bhasma ($33.2K), .

U Square Lifescience Private Limited — Export Portfolio & Destination Treemap

U Square Lifescience Private Limited pharmaceutical export portfolio — 2 products across 2 therapeutic categories. Source: Indian Customs (DGFT).

Who is U Square Lifescience Private Limited? — Company Overview & Market Position

U Square Lifescience Private Limited, established on May 17, 2007, is a privately held pharmaceutical company headquartered in Ahmedabad, Gujarat, India. The company specializes in the manufacturing and export of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Its Corporate Identification Number (CIN) is U24232GJ2007PTC050857. The authorized and paid-up capital of the company is ₹100,000.

As of the latest available data, U Square Lifescience employs approximately 19 professionals. The company's registered office is located at A-1101, 1102 & 1103, Solitaire Corporate Park, S.G. Highway, Sarkhej, Ahmedabad II, Gujarat, 380051, India.

What Does U Square Lifescience Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Heparin$400.0K 2Bhasma$33.2K

Product Portfolio — Top 2 by Export Value

U Square Lifescience Private Limited exports 2 pharmaceutical products across 2 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Heparin	Cardiovascular	$400.0K	8	0.1%	15
2	Bhasma	Ayurvedic & Herbal Products	$33.2K	3	8.0%	5

U Square Lifescience Private Limited exports 2 pharmaceutical products across 2 therapeutic categories with a total export value of $433.2K. The top category is Cardiovascular (92.3% of portfolio), followed by Ayurvedic & Herbal Products (7.7%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

U Square Lifescience Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

U Square Lifescience operates manufacturing facilities in Ahmedabad, Gujarat, India. The company specializes in the production of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Specific details regarding the capacities and certifications of these facilities are not publicly disclosed. However, the company emphasizes its commitment to quality and regulatory compliance in its operations. (usquare.biz)

3Key Leadership

The key leadership of U Square Lifescience Private Limited includes:

Rajiv Kumar: Director
Annapurna Rajiv Kumar: Director

Both directors have been associated with the company since its inception on May 17, 2007.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does U Square Lifescience Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

U Square Lifescience Private Limited has made efforts to expand its presence in regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company has prepared over 490 regulatory dossiers, including CTD, ACTD, and general dossiers, indicating its commitment to meeting international regulatory standards. (usquare.biz)

2Emerging Markets

The company has established a presence in emerging markets across Africa, Latin America, and Southeast Asia. U Square Lifescience has branch or subsidiary offices in countries such as Bolivia, Cambodia, Colombia, the Dominican Republic, Dubai, Myanmar, Nigeria, and Vietnam. Additionally, the company is in the process of incorporating offices in Canada, Malaysia, and Paraguay. (usquare.biz)

3Geographic Strategy

U Square Lifescience's geographic strategy involves expanding its footprint in both regulated and emerging markets. The company's presence in multiple countries across different continents indicates a diversified approach to mitigate concentration risks. By establishing offices in various regions, the company aims to strengthen its global distribution network and enhance market access. (usquare.biz)

U Square Lifescience Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding U Square Lifescience's FDA facility registrations, approved ANDAs, DMF filings, and inspection history are not publicly available. The company has prepared over 490 regulatory dossiers, including CTD, ACTD, and general dossiers, indicating its commitment to meeting international regulatory standards. (usquare.biz)

2WHO & EU GMP

U Square Lifescience emphasizes its commitment to quality and regulatory compliance in its operations. The company has prepared over 490 regulatory dossiers, including CTD, ACTD, and general dossiers, indicating its dedication to meeting international regulatory standards. (usquare.biz)

3CDSCO & Indian Regulatory

Specific details regarding U Square Lifescience's CDSCO manufacturing licenses, state drug controller approvals, and export NOCs are not publicly available. The company emphasizes its commitment to quality and regulatory compliance in its operations. (usquare.biz)

U Square Lifescience Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

U Square Lifescience operates in a competitive pharmaceutical industry, focusing on the manufacturing and export of finished pharmaceutical formulations. While specific competitors are not publicly disclosed, the company's emphasis on quality, regulatory compliance, and a diversified geographic presence positions it to effectively compete in both regulated and emerging markets. (usquare.biz)

2Key Differentiators

U Square Lifescience's key differentiators include its commitment to quality, strong regulatory capabilities, and a diversified geographic presence. The company has prepared over 490 regulatory dossiers, including CTD, ACTD, and general dossiers, indicating its dedication to meeting international regulatory standards. (usquare.biz)

3Strategic Position

U Square Lifescience's current strategic direction focuses on expanding its global footprint through a diversified geographic presence and a commitment to quality and regulatory compliance. The company's emphasis on contract manufacturing, formulation development, and packaging development supports its strategic objectives. (usquare.biz)

Buyer Due Diligence Brief — Evaluating U Square Lifescience Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

U Square Lifescience has demonstrated a commitment to quality and regulatory compliance in its operations. The company has prepared over 490 regulatory dossiers, including CTD, ACTD, and general dossiers, indicating its dedication to meeting international regulatory standards. (usquare.biz)

2Certifications to Verify

Importers should verify the following certifications when considering U Square Lifescience as a supplier:

FDA Facility Registration: Confirm the company's registration status with the U.S. Food and Drug Administration.
WHO-GMP Certification: Verify compliance with the World Health Organization's Good Manufacturing Practices.
EU GMP Certification: Ensure adherence to the European Union's Good Manufacturing Practices.
ISO Certification: Check for relevant International Organization for Standardization certifications.

Frequently Asked Questions — U Square Lifescience Private Limited

How many pharmaceutical products does U Square Lifescience Private Limited export from India?

U Square Lifescience Private Limited exports 2 pharmaceutical products across 2 therapeutic categories. The top exports are Heparin ($400.0K), Bhasma ($33.2K). Total export value is $433.2K.

What is U Square Lifescience Private Limited's total pharmaceutical export value?

U Square Lifescience Private Limited's total pharmaceutical export value is $433.2K, based on 11 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does U Square Lifescience Private Limited cover?

U Square Lifescience Private Limited exports across 2 therapeutic categories. The largest are Cardiovascular (92.3%, 1 products), Ayurvedic & Herbal Products (7.7%, 1 products).

Get Full U Square Lifescience Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.